Momenta Pharmaceuticals Announces Date of Fourth Quarter and Year End 2012 Financial Results Conference Call and Webcast

[at noodls] – CAMBRIDGE, Mass., Jan. 24, 2013 (GLOBE NEWSWIRE) — Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will release … more

View todays social media effects on MNTA

View the latest stocks trending across Twitter. Click to view dashboard

See who Momenta is hiring next, click here to view